Although novel research has shown that the N-methyl-D-aspartate ( NMDA ) receptor antagonist ketamine has rapidly acting , relatively sustained effects in treating depression , we predicted that , consistent with the existent literature on traditional antidepressants , patients with anxious depression would have a poorer antidepressant response .